Development and characterization of lactoferrin loaded poly(ε- Caprolactone) nanofibers

Journal of Biomedical Nanotechnology

Volumn 10, Issue 3, 2014, Pages 500-507

  James, Eric N ^a   Nair, Lakshmi S ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b University of Connecticut   (United States)

Author keywords

Extracellular Matrix (ECM); Lactoferrin; Nanofiber; Polycaprolactone (PCL); Tissue Engineering

Indexed keywords

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DRUG CARRIERS; DRUG COMPOUNDING; LACTOFERRIN; MATERIALS TESTING; MICE; NANOFIBERS; OSTEOBLASTS; POLYESTERS; RECOMBINANT PROTEINS; TISSUE SCAFFOLDS;

EID: 84893796956     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1717     Document Type: Article

References (40)

1. P. Aisen and I. Listowsky, Iron transport and storage proteins. Annu. Rev. Biochem. 49, 357 (1980).
2. P. F. Hennart, D. J. Brasseur, J. B. Delogne-Desnoeck, M. M. Dramaix, and C. E. Robyn, Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: Influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am. J. Clin. Nutr. 53, 32 (1991).
3. P. L. Masson and J. F. Heremans, Lactoferrin in milk from different species. Comp. Biochem. Physiol. B 39, 119 (1971).
4. B. T. Pentecost and C. T. Teng, Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J. Biol. Chem. 262, 10134 (1987).
5. J. A. Gibbons, R. K. Kanwar, and J. R. Kanwar, Lactoferrin and cancer in different cancer models. Front Biosci. (Schol. Ed.) 3, 1080 (2011).
6. M. Yeom, J. Park, B. Lee, S. Y. Choi, K. S. Kim, H. Lee, and D. H. Hahm, Lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells. Inflamm. Res. 60, 475 (2011).
7. E. R. Nemtsova, M. M. Utkin, and R. I. Iakubovskaia, Immunochemical comparison of lactoferrin of human milk and lactoferrin of neutrophils. Vopr. Med. Khim. 34, 127 (1988).
8. P. Drobni, J. Naslund, and M. Evander, Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral. Res. 64, 63 (2004).
9. A. A. Amini and L. S. Nair, Lactoferrin: A biologically active molecule for bone regeneration. Curr. Med. Chem. 18, 1220 (2011).
10. J. Cornish, K. E. Callon, D. Naot, K. P. Palmano, T. Banovic, U. Bava, M. Watson, J. M. Lin, P. C. Tong, Q. Chen, V. A. Chan, H. E. Reid, N. Fazzalari, H. M. Baker, E. N. Baker, N. W. Haggarty, A. B. Grey, and I. R. Reid, Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145, 4366 (2004).
11. F. Lorget, J. Clough, M. Oliveira, M. C. Daury, A. Sabokbar, and E. Offord, Lactoferrin reduces In vitro osteoclast differentiation and resorbing activity. Biochem. Biophys. Res. Commun. 296, 261 (2002).
12. A. Grey, T. Banovic, Q. Zhu, M. Watson, K. Callon, K. Palmano, J. Ross, D. Naot, I. R. Reid, and J. Cornish, The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18, 2268 (2004).
13. A. Malet, E. Bournaud, A. Lan, T. Mikogami, D. Tome, and A. Blais, Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation. Bone 48, 1028 (2011).
14. A. Grey, Q. Zhu, M. Watson, K. Callon, and J. Cornish, Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway. Mol. Cell Endocrinol. 251, 96 (2006).
15. K. Nakajima, Y. Kanno, M. Nakamura, X. D. Gao, A. Kawamura, F. Itoh, and A. Ishisaki, Bovine milk lactoferrin induces synthesis of the angiogenic factors VEGF and FGF2 in osteoblasts via the p44/p42 MAP kinase pathway. Biometals 24, 847 (2011).
16. D. Naot, A. Chhana, B. G. Matthews, K. E. Callon, P. C. Tong, J. M. Lin, J. L. Costa, M. Watson, A. B. Grey, and J. Cornish, Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. Bone 49, 217 (2011).
17. G. Wu, J. Luo, J. S. Rana, R. Laham, F. W. Sellke, and J. Li, Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc. Res. 69, 512 (2006).
18. M. I. Santos and R. L. Reis, Vascularization in bone tissue engineering: Physiology, current strategies, major hurdles and future challenges. Macromol. Biosci. 10, 12 (2010).
19. R. Takaoka, Y. Hikasa, K. Hayashi, and Y. Tabata, Bone regeneration by lactoferrin released from a gelatin hydrogel. J. Biomater. Sci. Polym. Ed. 22, 1581 (2011).
20. J. A. Matthews, G. E. Wnek, D. G. Simpson, and G. L. Bowlin, Electrospinning of collagen nanofibers. Biomacromolecules 3, 232 (2002).
21. C. T. Laurencin and L. S. Nair (eds.), Nanotechnology and Tissue Engineering the Scaffold, CRC Press, Taylor & Francis Group, New York (2008).
22. C. H. Lee, H. J. Shin, I. H. Cho, Y. M. Kang, I. A. Kim, K. D. Park, and J. W. Shin, Nanofiber alignment and direction of mechanical strain affect the ECM production of human ACL fibroblast. Biomaterials 26, 1261 (2005).
23. J. S. Choi, S. J. Lee, G. J. Christ, A. Atala, and J. J. Yoo, The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 29, 2899 (2008).
24. J. M. Corey, C. C. Gertz, B. S. Wang, L. K. Birrell, S. L. Johnson, D. C. Martin, and E. L. Feldman, The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater. 4, 863 (2008).
25. H. Singh, E. James, H. Kan, L. S. Nair, Fabrication and evaluation of resveratrol loaded polymeric nanofibers. J. Biomat. Tissue Eng. 2, 228 (2012).
26. J. G. Merrella, S. W. McLaughlin, L. Tie, C. T. Laurencin, A. F. Chen, and L. S. Nair, Curcumin loaded Poly(ε-Caprolactone) nanofibers: Diabetic wound dressing with antioxidant and antiinflammatory properties. Clin Exp Pharmacol Physiol. 36, 1149 (2009).
27. S. Sahoo, L. T. Ang, J. C. Goh, and S. L. Toh, Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J. Biomed. Mater. Res. A 93, 1539 (2010).
28. M. D. Schofer, S. Fuchs-Winkelmann, C. Grabedunkel, C. Wack, R. Dersch, M. Rudisile, J. H. Wendorff, A. Greiner, J. R. Paletta, and U. Boudriot, Influence of poly(L-lactic acid) nanofibers and BMP-2- containing poly(L-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. Scientific World Journal 8, 1269 (2008).
29. S. Ramakrishna, An Introduction to Electrospinning and Nanofibers, Hackensack, World Scientific, NJ (2005).
30. G. Eda and S. Shivkumar, Bead-to-fiber transition in electrospun polystyrene. J. Appl. Polym. Sci. 106, 475 (2007).
31. T. Lin, H. X. Wang, H. M. Wang, and X. Wang, The charge effect of cationic surfactants on the elimination of fibre beads in the electrospinning of polystyrene. Nanotechnology 15, 1375 (2004).
32. A. Chuachamsai, S. Lertviriyasawat, and P. Danwanichakul, Spinnability and defect formation of chitosan/poly vinyl alcohol electrospun nanofibers. Thammasat. Int. J. Sc. Tech. 13, 24 (2008).
33. J. Yu, S. Fridrikh, and G. Rutledge, The role of elasticity in the formation of electrospun fibers. Polymer. 47, 4789 (2006).
34. G. H. McKinley, Visco-elasto-cappilary thinning and break-up of complex fluids. Pheology Reviews 1 (2005).
35. S. Liu, Y. Su, and Y. Chen, Fabrication, surface properties and protein encapsulation/release studies of electrospun gelatin nanofibers. J. Biomater. Sci. Polym. Ed. 22, 945 (2011).
36. S. Wongsasulak, K. M. Kit, D. J. McClements, T. Yoovidhya, and J. Weiss, The effect of solution properties on the morphology of ultrafine electrospun egg albumen-PEO composite fibers. Polymer 48, 448 (2007).
37. J. M. Hadden, M. Bloemendal, P. I. Haris, S. K. Srai, and D. Chapman, Fourier transform infrared spectroscopy and differential scanning calorimetry of transferrins: human serum transferrin, rabbit serum transferrin and human lactoferrin. Biochim. Biophys. Acta. 1205, 59 (1994).
38. L. Ghasemi-Mobarakeh, M. P. Prabhakaran, M. Morshed, M. Nasr-Esfahani, and S. Ramakrishna, Electrospun poly(εcaprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Biomaterials 29, 4532 (2008).
39. Huang, D. Bethell, C. Card, J. Cornish, T. Marchbank, D. Wyatt, K. Mabery, and R. Playford, Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth. In Vitro Cell. Dev. Biol. Animal 44, 464 (2008).
40. A. Amini and L. Nair, Evaluation of the bioactivity of recombinant human lactoferrin towards murine osteoblast-like cells for bone tissue engineering. Tissue Eng. Part A 19, 9 (2012).